Signal Transduction and Targeted Therapy Impact Factor, Indexing, Ranking

Signal Transduction and Targeted Therapy Impact Factor, Indexing, Ranking

Signal Transduction and Targeted Therapy (STTr) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology. Springer is the publisher of this esteemed journal. The P-ISSN assigned to Signal Transduction and Targeted Therapy is 2095-9907 and its abbreviated form is Signal Transduct Target Ther.


Signal Transduction and Targeted Therapy Aim and Scope

Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, autoimmune disorders, and others. This journal focuses on cutting-edge advances both experimentally and clinically.


Signal Transduction and Targeted Therapy Details


Journal title Signal Transduction and Targeted Therapy (STTr)
Abbreviation Signal Transduct Target Ther
Print ISSN 2095-9907
Online ISSN 2059-3635
Publisher Name Springer
Editor-in-chief Prof. Carlo M. Croce, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
Subject Category Biochemistry Genetics and Molecular Biology

Signal Transduction and Targeted Therapy Abbreviation

Signal Transduction and Targeted Therapy Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Signal Transduction and Targeted Therapy Journal is Signal Transduct Target Ther.


Signal Transduction and Targeted Therapy Ranking

The Ranking of Signal Transduction and Targeted Therapy in 2026 is 156. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


Signal Transduction and Targeted Therapy Impact Factor

The Impact Factor of Signal Transduction and Targeted Therapy in 2026 is 37.2. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


Signal Transduction and Targeted Therapy SCImago

The SCImago of Signal Transduction and Targeted Therapy in 2026 is 6.630. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


Signal Transduction and Targeted Therapy H-Index

The H-Index of Signal Transduction and Targeted Therapy in 2026 is 83. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


Signal Transduction and Targeted Therapy Quartile

The Quartile of Signal Transduction and Targeted Therapy is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


Signal Transduction and Targeted Therapy Indexing

The Signal Transduction and Targeted Therapy is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


Signal Transduction and Targeted Therapy Metrics for 2026


Abbreviation Signal Transduct Target Ther
Access type Open Access
Impact Factor 37.2
SJR 6.630
SNIP 4.133
Ranking 156
CiteScore 31.5
H-Index 83

Signal Transduction and Targeted Therapy Editorial Board

The Editor-in-chief of Signal Transduction and Targeted Therapy is Prof. Carlo M. Croce, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA


Signal Transduction and Targeted Therapy Submission/Processing Fee (APC)

Signal Transduction and Targeted Therapy Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Signal Transduction and Targeted Therapy is $3190, £2390, €2690


Signal Transduction and Targeted Therapy Call for paper

Signal Transduction and Targeted Therapy Call for paper : Signal Transduction and Targeted Therapy invites original research contributions for consideration of publication in Signal Transduction and Targeted Therapy journal.

Journal seeking submissions in the broad areas of Biochemistry Genetics and Molecular Biology that align with journal's focus on Biochemistry Genetics and Molecular Biology.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in Signal Transduction and Targeted Therapy

Publishing in Signal Transduction and Targeted Therapy involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Biochemistry Genetics and Molecular Biology.
  • Familiarize Yourself: Read and understand the aims and scope of Signal Transduction and Targeted Therapy to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Signal Transduction and Targeted Therapy guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Signal Transduction and Targeted Therapy FAQ

is Signal Transduction and Targeted Therapy journal indexed in PubMed?

Yes, the Signal Transduction and Targeted Therapy journal is indexed in PubMed.

is Signal Transduction and Targeted Therapy journal indexed in Scopus?

Yes, the Signal Transduction and Targeted Therapy journal is indexed in Scopus.

is Signal Transduction and Targeted Therapy journal indexed in UGC?

Yes, the Signal Transduction and Targeted Therapy journal is indexed in UGC.

is Signal Transduction and Targeted Therapy journal indexed in Index Copernicus?

No, the Signal Transduction and Targeted Therapy journal is not indexed in Index copernicus.

is Signal Transduction and Targeted Therapy a predatory journal?

No, Signal Transduction and Targeted Therapy journal is not a predatory journal.

What is the Imptact Factor of Signal Transduction and Targeted Therapy?

The Impact Factor of the Signal Transduction and Targeted Therapy is 37.2.

What is the Ranking of Signal Transduction and Targeted Therapy?

The Ranking of the Signal Transduction and Targeted Therapy is 156.

is Signal Transduction and Targeted Therapy peer reviewed journal?

Yes the Signal Transduction and Targeted Therapy (STTr) journal is a peer-reviewed journal.

is Signal Transduction and Targeted Therapy a good journal?

Yes the Signal Transduction and Targeted Therapy journal is a peer-reviewed journal and good to publish your paper.

What is Signal Transduction and Targeted Therapy?

Signal Transduction and Targeted Therapy (STTr) is a scholarly journal dedicated to publishing research in the field of Biochemistry Genetics and Molecular Biology. Springer is the publisher of this esteemed journal.

is Signal Transduction and Targeted Therapy open access?

Yes, Signal Transduction and Targeted Therapy is a open access journal.


Impact factor List